Actively Recruiting
Non-intubated vs Intubated Anesthesia for Tracheal and Carinal Reconstruction
Led by Shuben Li · Updated on 2025-07-15
176
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and outcomes of two anesthesia approaches for tracheal and carinal reconstruction in patients with airway or tracheal diseases. This trial compares the traditional intubated anesthesia method, which uses endotracheal ventilation but can obstruct the surgical field, with a newer non-intubated anesthesia technique that may offer advantages during surgery. The study aims to determine if the non-intubated approach has similar or better short-term and long-term results compared to the conventional method. Participants will be randomly assigned to one of two groups: one receiving non-intubated tracheal and carinal reconstruction, and the other receiving the standard intubated procedure. Both groups undergo the surgical reconstruction, but the anesthesia delivery differs. The trial does not use masking or blinding, and the procedures are performed under medical supervision to assess their comparative effects on perioperative outcomes. During the study, researchers will monitor participants closely for outcomes such as conversion rates, postoperative complications, operative time, length of hospital and ICU stays, blood loss, reconstruction time, and drainage volume during the hospital stay up to 30 days after surgery. They will also track disease-free and overall survival rates for one year post-surgery. Participants will receive all necessary evaluations and care throughout the study period to ensure safety and accurate data collection.
CONDITIONS
Brief Title
Tubeless Tracheal and Carinal Reconstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Airway diseases diagnosed by chest enhanced CT and bronchoscopy
- Age between 18 and 80 years old
- ASA (American Society of Anesthesiologists) stage I to III
- Signed informed consent
You will not qualify if you...
- History of congestive heart failure, angina without good control, ECG-proved myocardial infarction, uncontrolled hypertension, significant valvulopathy, or high-risk arrhythmia
- Severe systemic diseases such as active infection, poorly controlled diabetes, coagulation disorders, hemorrhagic tendency, or current thrombolysis/anticoagulant therapy
- Airway anatomical abnormalities due to previous surgery
- Presence of other malignancies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Postoperative in-hospital stay up to 30 days
Participants undergo either non-intubated or intubated tracheal and carinal reconstruction surgery and receive immediate post-operative care during their hospital stay.
Continuous monitoring during hospital stay
Duration - Up to 1 year after surgery
Participants are followed for their recovery and survival outcomes after surgery.
Follow-up visits as scheduled up to 1 year
Trial Site Locations
Total: 1 location
1
the First Affiliated Hospital of Guangzhou Medical University
Guangdong, Gaungzhou, China, 510120
Actively Recruiting
Research Team
S
Shuben Li
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here